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Abstract:  The renin-angiotensin system (RAS) has an established role in pathogenesis   
of metabolic etiologies. Angiotensin converting enzyme (ACE) is an important component  
of RAS that may influence metabolic outcomes in adipose tissue. The deletion “D allele”,  
of ACE gene I/D (insertion/deletion) polymorphism has been shown to be associated with 
rise in the serum level of ACE. This study is designed to correlate the association between 
ACE gene I/D polymorphism and obesity in adult population of Pakistan. Our study included 
535 individuals; 147 normal with body mass index (BMI) 19-24.9, 183 overweight   
(BMI 26-29.9) and 205 obese (BMI > 30). The individuals were genotyped for ACE gene  
I/D polymorphism. The ratio of ACE gene II and ID genotypes were not significantly 
different among normal, overweight and obese individuals. However, the DD genotype in 
normal, overweight and obese individuals was 12.9%, 18.0% and 28.8% respectively.   
DD genotype is significantly high (P = 0.002) in obese than in overweight and normal 
individuals. Thus the results of this study may suggest a possible association of the D allele 
in adipogenesis and adipocyte metabolism by affecting the ACE plasma level. 
 
Keywords: Renin-angiotensin system, Angiotensin converting enzyme, Insertion/deletion 
polymorphism, Body mass index. 
 
Introduction 
Obesity has become a global problem with high rise in south Asian countries including 
Pakistan, where drifty transitions in life style have accelerated gene-environment imbalances. 
Many genes have been reported to have a complicated effect on obesity [21]. The components 
of rennin-angiotensin system (RAS) are expressed in metabolically active adipose tissue, 
skeletal muscle and pancreas [10] and may represent an important link between obesity and 
its complications. 
 
An important molecule of RAS is Angiotensin II which regulates blood pressure and salt and 
water balance. Previous studies show that Ang II has an adipogenic affect on adipocyte 
growth and development through interacting with its receptor [7, 11, 19]. Ang II precursor, 
angiotensinogen, is expressed and nutritionally and hormonally regulated in adipose tissue 
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[8]. Furthermore, it has been observed that treating cultured adipocytes with Ang II increases 
triglyceride storage and the activities of lipogenic enzymes [9]. 
 
Angiotensinogen (AGT), the precursor of angiotensin, is synthesized primarily by the liver 
and is secreted into the circulation, where it is cleaved by renin to the decapeptide angiotensin 
I. Angiotensin I is subsequently converted to the octapeptide angiotensin II by angiotensin-
converting enzyme (ACE) [15]. Though there are many different types of polymorphisms in 
the ACE gene but the 287 bp insertion/deletion (I/D) polymorphism in intron 16 of ACE gene 
is an important precursor for non communicable diseases (NCDs) including diabetes, obesity 
and hypertension. There are three distinguished genotypes of ACE gene I/D polymorphism; 
I/I, I/D and D/D based on presence or absence of 287bp alu repeat. The DD homozygote 
individuals have a higher concentration of serum Ang II [16]. Angiotensin II functions as a 
vasoconstrictor and inactivates bradykinin which is a vasodilator [20]. 
 
We have previously shown that ACE gene I/I genotype has a significant association   
(P < 0.05) with essential hypertension in young Pakistani patients [12]. In another study we 
reported the high frequencies of ACE gene I allele in male diabetic nephropathy patients of 
Pakistan [13]. Here we demonstrate whether or not the ACE gene I/D polymorphism is 
associated with development of obesity in Pakistani population. 
  
Materials and Methods 
Subjects 
Our study included 535 individuals out of which 147 were normal (BMI 19-24.9) and   
183 were overweight (BMI 26-29.9) and 205 were obese (BMI > 30). 5ml blood samples 
were collected with informed consents. Comparisons were made among individual with the II, 
ID, and DD genotypes of ACE gene in obese, overweight and normal individuals. 
 
Methods 
DNA was isolated from peripheral blood samples of the subjects using standard organic 
method [17]. ACE gene I /D polymorphism were investigated by polymerase chain reaction 
[2]. Amplification was done in a final volume of 15µl containing 20ng genomic DNA,   
1X PCR buffer (Bioline), 0.45mM MgCl2, 200µM dNTPs (Promega), 1µM each forward and 
reverse primer, 1U Taq DNA polymerase (Institute of Biomedical and genetic engineering, 
Islamabad, Pakistan). Amplification was done with initial denaturing at 94
oC for 3 min,   
35 cycles each consisting of denaturing at 94
oC for 45 sec, annealing at 58
oC for 45 sec, 
extension at 72
oC for 45 sec and final extension for 10 min at 72
oC. Amplified DNA products 
were run on 2% (w/v) agarose gel containing 0.5µg/ml ethidium bromide at constant power 
supply of 200 volts. I allele was resolved as 490bp fragment and D allele as 190bp fragment; 
size depicted by 100bp ladder (Promega). 
 
Statistical analysis 
Finally, statistical analysis was done by SPSS for windows, version 10.0 (SPSS Inc., Chicago, 
USA). 
 
Results 
The statistical results showed that the ratio of ACE gene “II genotype” is 0.33, 0.32, and 0.26 
in normal, over-weight and obese individuals respectively whereas; the ratio of “ID genotype” 
is 0.53, 0.49 and 0.44 in normal, over-weight and obese individuals respectively (Table 1). 
Therefore, these results show that the ratio of II and ID genotypes were not significantly 
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different among normal, overweight and obese individuals. However the ratio of   
DD genotype was higher in obese individuals i.e. 0.28 than in normal and overweight 
individuals i.e. 0.12 and 0.18 respectively (Table 1). This difference of DD genotype was 
statistically significant with P value 0.002 (P < 0.05) among obese, overweight and normal 
individuals (Fig. 1). 
 
  Table 1. Distribution of ACE II, DD and ID genotypes in Pakistani individuals 
Groups II  DD  ID  TOTAL 
Normal 
(BMI = 19-24.9) 
49 
(0.33) 
19 
(0.12) 
79 
(0.53)  147 
Over Weight 
(BMI = 25-29.9) 
60 
(0.32) 
33 
(0.18) 
90 
(0.49)  183 
Obese 
(BMI ≥ 30) 
55 
(0.26) 
59 
(0.28 ) 
91 
(0.44)  205 
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Fig. 1 Comparison of DD genotype distribution observed in normal,  
over-weight and obese individuals. DD genotype was significantly high  
in obese individuals compared to normal individuals (P = 0.002) 
 
Graphical representation of  distribution of ACE II, DD and ID genotypes in Pakistani 
individuals in the form of a bar graph is shown in Fig. 2. One Way Analysis of variance 
(ANOVA) was carried out for comparing means by using multiple F Tests. Comparison of 
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mean ± SEM DD genotype distribution in normal, over- weight and obese individuals is 
shown in Fig. 2 and it was seen that DD genotype was significantly high (P < 0.05) in obese 
individuals as compared to normal individuals.  
 
 
Fig. 2 Distribution of ACE ID, II and DD genotypes in Pakistani individuals 
 
Discussion 
In this study we investigated the association of obesity with ACE gene DD genotype in 
Pakistani population. We collected samples from federal capital of Pakistan where a pool of 
different ethnic groups of the country live. In our study a significant association (P < 0.05) 
was found between the ACE gene DD genotype and obesity. This correlates with the finding 
that subjects with the DD genotype have enhanced ACE expression, which results in higher 
levels of Ang II, resulting in its enhanced modulation and interaction with genes involved in 
adipogenesis including FAS, apoE and effecting adipocyte lipid metabolism. 
 
A recent study in Czech population showed that a strong significant effect of DD genotype 
was observed in the phenotypes of extreme obesity with the highest carbohydrate intake 
where ACE I/D polymorphism could represent a gene modulator of carbohydrate intake in 
morbidly obese Czech population [22]. 
 
Age and gender dependent associations between the ACE gene deletion polymorphism   
(DD genotype) and hypertension have been demonstrated in the Caucasian and Chinese [1, 3, 
5, 18]. It has been observed that a large number of patients with obesity have a higher 
prevalence of developing hypertension [14]. Since Ang II is classically known to regulate the 
blood pressure [6] there may be a direct relationship in hypertension and obesity as Ang II is 
expressed in adipocytes. 
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The association of the ACE DD genotype with obesity in the Pakistani population is based on 
a limited number of individuals (n = 535) and a more extensive survey is required to confirm 
this finding, which may have possible diagnostic and therapeutic implications. Other hunger 
and satiety signals such as ghrelin and peptide Y are potentially attractive therapeutic 
strategies for treatment of obesity and its complications. These recent discoveries should lead 
to novel strategies for treatment of obesity and hypertension. 
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